| Typicality: | 0.424 |
| Saliency: | 0.462 |
| over the past 18 months | 16 | temporal |
| in designing a drug repurposing pathway | 11 | other |
| on its medium-term plan | 10 | other |
| group → made → significant progress | 42 |
| group → make → significant progress | 16 |
| group → made → substantial progress | 11 |
| group → made → considerable progress | 6 |
| negative | neutral | positive |
| 0.009 | 0.146 | 0.845 |
| Raw frequency | 75 |
| Normalized frequency | 0.462 |
| Modifier score | 0.700 |
| Perplexity | 73.157 |